Stocks and Investing Stocks and Investing
Tue, January 25, 2022
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022

Patrick Trucchio Maintained (ALNY) at Strong Buy with Increased Target to $350 on, Jan 20th, 2022


Published on 2024-10-27 19:22:03 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $250 to $350 on, Jan 20th, 2022.

Patrick has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $108 on, Thursday, October 28th, 2021


These are the ratings of the 8 analyists that currently disagree with Patrick


  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $215 on, Tuesday, January 18th, 2022
  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $205 on, Monday, November 22nd, 2021
  • Luca Issi of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $225 on, Monday, November 22nd, 2021
  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $273 on, Monday, November 22nd, 2021
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $200 on, Monday, November 1st, 2021
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $200 on, Friday, October 29th, 2021
  • Esther Rajavelu of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $215 on, Monday, October 4th, 2021